GUGLIESI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 6.980
AS - Asia 3.952
EU - Europa 3.802
SA - Sud America 432
Continente sconosciuto - Info sul continente non disponibili 266
AF - Africa 143
OC - Oceania 43
Totale 15.618
Nazione #
US - Stati Uniti d'America 6.747
IT - Italia 1.681
SG - Singapore 1.464
CN - Cina 937
VN - Vietnam 356
BR - Brasile 320
IE - Irlanda 272
DE - Germania 267
SE - Svezia 257
GB - Regno Unito 235
FR - Francia 232
KR - Corea 203
JP - Giappone 193
AT - Austria 181
IN - India 178
FI - Finlandia 172
CA - Canada 148
HK - Hong Kong 147
UA - Ucraina 89
ID - Indonesia 79
PL - Polonia 78
SA - Arabia Saudita 77
NL - Olanda 69
BD - Bangladesh 52
TR - Turchia 52
SN - Senegal 50
BE - Belgio 48
ES - Italia 40
AR - Argentina 35
AU - Australia 34
IQ - Iraq 34
TW - Taiwan 33
PK - Pakistan 31
MX - Messico 29
RU - Federazione Russa 28
CO - Colombia 25
DK - Danimarca 23
GR - Grecia 23
ZA - Sudafrica 23
IL - Israele 22
IR - Iran 20
JM - Giamaica 19
EC - Ecuador 18
CH - Svizzera 15
HR - Croazia 14
NO - Norvegia 14
CL - Cile 13
VE - Venezuela 13
CR - Costa Rica 12
MA - Marocco 12
PH - Filippine 12
UG - Uganda 12
JO - Giordania 11
TH - Thailandia 11
HU - Ungheria 9
NZ - Nuova Zelanda 9
EG - Egitto 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
SK - Slovacchia (Repubblica Slovacca) 7
MY - Malesia 6
TN - Tunisia 6
AL - Albania 5
BG - Bulgaria 5
ET - Etiopia 5
KE - Kenya 5
PT - Portogallo 5
GT - Guatemala 4
NP - Nepal 4
RO - Romania 4
UZ - Uzbekistan 4
BB - Barbados 3
CG - Congo 3
CI - Costa d'Avorio 3
DZ - Algeria 3
HN - Honduras 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
MU - Mauritius 3
NG - Nigeria 3
OM - Oman 3
PR - Porto Rico 3
PY - Paraguay 3
RS - Serbia 3
SV - El Salvador 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GD - Grenada 2
KW - Kuwait 2
LV - Lettonia 2
PE - Perù 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
ZM - Zambia 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
Totale 15.335
Città #
Singapore 931
Ashburn 685
Chandler 679
San Jose 513
Santa Clara 348
Beijing 320
Dublin 270
Turin 233
Dallas 230
Houston 168
Vienna 159
Fairfield 151
Los Angeles 139
Torino 137
Milan 131
Ann Arbor 120
Sovicille 115
New York 111
Seoul 111
Tokyo 110
Rome 106
Hefei 100
The Dalles 96
Ho Chi Minh City 95
Nyköping 95
Seattle 95
Columbus 92
Jacksonville 90
Woodbridge 83
Lauterbourg 80
Wilmington 78
Hong Kong 76
Hanoi 74
Council Bluffs 73
Dearborn 70
Jakarta 68
Munich 66
Warsaw 64
Guangzhou 63
Princeton 61
Cambridge 60
Medford 58
Villeurbanne 58
Buffalo 55
Pisa 55
Boardman 49
Boston 49
Redwood City 45
Dong Ket 44
Helsinki 42
Jeddah 42
Frankfurt am Main 41
Bengaluru 39
Fremont 39
Lappeenranta 38
Shanghai 36
São Paulo 36
Turku 36
Chicago 35
Atlanta 32
Brusasco 32
Mumbai 31
Washington 30
Chennai 28
Phoenix 27
Naples 25
Toronto 25
London 23
Orem 23
Pittsburgh 23
Redondo Beach 23
Brussels 22
Denver 22
Nanjing 22
Florence 21
Philadelphia 21
Montreal 20
San Diego 20
Stockholm 20
Taipei 19
Nuremberg 17
Bologna 16
Brooklyn 16
San Mauro Torinese 16
Baghdad 15
Gongju 15
Istanbul 15
Norwalk 15
Orange 15
Baltimore 14
Cardiff 14
Lahore 14
Ta'if 14
Kingston 13
Las Vegas 13
Rochester 13
San Francisco 13
Aarhus 12
Birmingham 12
Bogotá 12
Totale 8.936
Nome #
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 501
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 411
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 377
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 311
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 308
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 302
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 274
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 272
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 263
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 261
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 259
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 258
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 254
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 251
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 238
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 231
Tuning the Orchestra: HCMV vs. Innate Immunity. 221
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 216
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 212
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 209
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 203
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 201
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 199
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 195
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 194
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 194
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 192
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 192
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 191
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 189
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 185
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 181
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 177
Where do we stand after decades of studying human cytomegalovirus? 176
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 172
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 169
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 166
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 164
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 162
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 160
45th International Herpesvirus Workshop 158
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 154
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 152
50° Congresso Nazionale della Società Italiana di Microbiologia 150
Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. 146
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 145
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 142
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 137
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 136
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 134
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 133
Targeting PAD-mediated citrullination to treat human papillomavirus infections 132
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 131
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 130
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 128
The impact of fatty acid synthase on HSV-1 infection dynamics [*Camilla Albano, Linda Trifirò co-first authors] 127
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 127
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 126
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 126
Biotechnology, Industry and Research in Piemonte from 1990 to 2003 : an update 125
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 125
Detection of IFI16 in body fluids 123
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 123
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 122
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 121
Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha 118
The interferon-inducible IFI16 gene acts as a restriction factor for human citomegalovirus replication 117
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 117
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 115
Interplay Between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 114
The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. 112
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 111
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection 109
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene 109
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 108
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 106
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 101
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 101
INVESTIGATING PAD-MEDIATED CITRULLINATION IN HPV-DRIVEN HEAD AND NECK SQUAMOUS CELL CARCINOMA 100
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 98
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 98
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding 97
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 96
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 90
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 86
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 86
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 85
Metabolomic and Genomic Characterization of Human Cytomegalovirus in Congenital Infection: Towards Predictive Biomarkers of Clinical Outcome 85
The Impact of Fatty Acid Synthase on HSV-1 Infection Dynamics 85
INTERPLAY BETWEEN HCMV PROTEIN pp65 AND cGAS-STING PATHWAY: MODULATING VIRAL INFECTIVITY VIA LIPID METABOLISM 80
ANTIHERPETIC ACTIVITY OF IMIQUIMOD-BASED RUTHENIUM METAL COMPLEXES 79
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 75
Targeting PAD-mediated citrullination to treat human papillomavirus infections 75
Targeting HSV-1 through FASN inhibitors: implications for Alzheimer's Disease 73
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 68
The Long Shadow of Early HCMV-HIV Coinfection: Epidemiology, Pathogenesis, and Immune Consequences 29
Virus-Driven Lipid Dysregulation as a Convergent Mechanism in Alzheimer’s Disease 24
Targeting peptidyl-arginine deiminase 4 suppresses SARS-CoV-2 replication and modulates the inflammatory response 18
Metabolic Vulnerabilities as Antiviral Targets in HSV-1 Infection 9
Totale 15.618
Categoria #
all - tutte 44.588
article - articoli 0
book - libri 0
conference - conferenze 27.729
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.317


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022695 0 0 0 82 35 30 32 35 35 63 234 149
2022/20231.853 99 109 29 237 201 423 91 152 268 55 89 100
2023/20241.039 142 154 74 51 90 105 49 68 22 65 82 137
2024/20252.559 83 267 222 210 406 180 140 137 143 142 264 365
2025/20265.457 583 332 370 722 573 242 790 156 527 369 260 533
2026/20271.028 175 264 373 216 0 0 0 0 0 0 0 0
Totale 15.618